Yolanda C. Nesbeth, Ph.D.
Affiliations: | 2010 | Immunology and Microbiology | Dartmouth College, Hanover, NH, United States |
Area:
ImmunologyGoogle:
"Yolanda Nesbeth"Parents
Sign in to add mentor| Jose R. Conejo-Garcia | grad student | 2010 | Dartmouth | |
| (Endogenous antitumor immunity elicited by adoptively transferred lymphocytes through CCL5 and CD40L signaling, and dendritic cell depletion.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Cubillos-Ruiz JR, Martinez D, Scarlett UK, et al. (2010) CD277 is a negative co-stimulatory molecule universally expressed by ovarian cancer microenvironmental cells. Oncotarget. 1: 329-38 |
| Nesbeth Y, Conejo-Garcia JR. (2010) Harnessing the effect of adoptively transferred tumor-reactive T cells on endogenous (host-derived) antitumor immunity. Clinical & Developmental Immunology. 2010: 139304 |
| Nesbeth YC, Martinez DG, Toraya S, et al. (2010) CD4+ T cells elicit host immune responses to MHC class II-negative ovarian cancer through CCL5 secretion and CD40-mediated licensing of dendritic cells. Journal of Immunology (Baltimore, Md. : 1950). 184: 5654-62 |
| Scarlett UK, Cubillos-Ruiz JR, Nesbeth YC, et al. (2009) In situ stimulation of CD40 and Toll-like receptor 3 transforms ovarian cancer-infiltrating dendritic cells from immunosuppressive to immunostimulatory cells. Cancer Research. 69: 7329-37 |
| Cubillos-Ruiz JR, Engle X, Scarlett UK, et al. (2009) Polyethylenimine-based siRNA nanocomplexes reprogram tumor-associated dendritic cells via TLR5 to elicit therapeutic antitumor immunity. The Journal of Clinical Investigation. 119: 2231-44 |
| Nesbeth Y, Scarlett U, Cubillos-Ruiz J, et al. (2009) CCL5-mediated endogenous antitumor immunity elicited by adoptively transferred lymphocytes and dendritic cell depletion. Cancer Research. 69: 6331-8 |
| Huarte E, Cubillos-Ruiz JR, Nesbeth YC, et al. (2008) Depletion of dendritic cells delays ovarian cancer progression by boosting antitumor immunity. Cancer Research. 68: 7684-91 |
| Huarte E, Cubillos-Ruiz JR, Nesbeth YC, et al. (2008) PILAR is a novel modulator of human T-cell expansion. Blood. 112: 1259-68 |